COVID-19 Resources

As we are all working to better understand and react to the impacts of COVID-19 around the world, please know that ISMP is here for you. We appreciate all of the selfless dedication of healthcare professionals during this unprecedented event, and our first priority is to help them with the resources that they need to keep themselves and their patients safe. Below are links to medication safety information that may be useful for COVID-19 response efforts.

Error Reporting for EUA Drugs

• Mandatory for Vaccines | VAERS- Report an Adverse Event Step 1

• Mandatory for Monoclonal Antibodies | FDA MedWatch Online Voluntary Reporting Form

• Voluntary to Help Communicate Safety Issues | ISMP Error Reporting

Vaccine Information

• ECRI Position Paper | Pregnancy and COVID-19 Vaccines

• IMSN | COVID-19 Vaccine Safety Interest Group

• ISMP, ASHP, USP | FAQ for Optimizing COVID-19 Vaccine Preparation and Safety

• FDA | COVID-19 Fact Sheets

• ASHP | COVID-19 Vaccines

Safety Alerts

• [Special Alert] January 3, 2022 Medication Safety Issues with Newly Authorized PAXLOVID

• [NAN Alert] December 6, 2021 Age-Related COVID-19 Vaccine Mix-Ups

• [NAN Alert] October 15, 2021 Mix-Ups Between the Influenza (Flu) Vaccine and COVID-19 Vaccines

ISMP Articles

• [June 30, 2022] Additional risk of age-related mix-ups now that our youngest patients are eligible for COVID-19 vaccines

• [June 30, 2022] Numerous Wrong Dose Errors with PAXLOVID

• [June 2, 2022] PAXLOVID drug interaction

• [November 18, 2021] Age-Related COVID-19 Vaccine Mix-Up

• [November 18, 2021] Multiple Error Pathways with the Monoclonal Antibodies, Casirivimab and Imdevimab

• [November 4, 2021] Adult and Pediatric Coronavirus Disease 2019 (COVID-19) Vaccine Mix-Ups are Predictable

• [October 7, 2021] Mix-Ups Between the Influenza (Flu) Vaccine and COVID-19 Vaccines

• [April 21, 2021] Learning from 4 months of COVID-19 Vaccinations

• More..